Neuphoria Therapeutics Inc.
NEUP
Pozycja w akcjach
#29124
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Cena akcji
$3.92
Ostatnia synchronizacja: 2026-07-31
Kapitalizacja rynkowa
$21.16M
Zmiana (1 dzień)
-0.13%
Zmiana (1 rok)
60,767.52%
Kraj
US
Handel Neuphoria Therapeutics Inc. (NEUP)
Kategoria
Healthcare
Historia ceny akcji dla Neuphoria Therapeutics Inc. (NEUP)
Najwyższa cena zamknięcia: $0.01 dnia 2023-08-01
Najniższa cena zamknięcia: $0.56 dnia 1999-12-01
Najniższa cena zamknięcia: $0.56 dnia 1999-12-01
Historia cen akcji firmy Neuphoria Therapeutics Inc. od 1999 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2023 | -78.35% |
| 2022 | -97.66% |
| 2021 | 1,363.12% |
| 2020 | 63.69% |
| 2019 | -30.83% |
| 2018 | -71.66% |
| 2017 | 18.70% |
| 2016 | -12.16% |
| 2015 | -19.29% |
| 2014 | -47.97% |
| 2013 | 95.06% |
| 2012 | -36.40% |
| 2011 | -90.46% |
| 2010 | 1,655.11% |
| 2009 | 133.43% |
| 2008 | -61.74% |
| 2007 | 121.34% |
| 2006 | 1.97% |
| 2005 | -16.73% |
| 2004 | -11.05% |
| 2003 | -22.47% |
| 2002 | -28.01% |
| 2001 | -20.19% |
| 2000 | -11.88% |
| 1999 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.63 | -3.92% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
